SNCA antibody (pSer129)
Quick Overview for SNCA antibody (pSer129) (ABIN372588)
Target
See all SNCA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer129
-
Specificity
- Recognizes the ~15 kDa alpha-Synuclein protein phosphorylated at Ser129. Immunolabeling is blocked by the phosphopeptide used as antigen but not by the corresponding dephosphopeptide.
-
Cross-Reactivity (Details)
-
Species reactivity (expected):Bovine, Canine, Human, Mouse and non-Human Primates.
Species reactivity (tested):Rat. -
Purification
- Affinity Chromatography.
-
Immunogen
- Phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser129 of alpha Synuclein.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: 1/1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg/mL BSA and 50 % Glycerol.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody undiluted (in aliquots) at-20 °C.
-
-
- SNCA (Synuclein, alpha (SNCA))
-
Alternative Name
- alpha-Synuclein / SNCA
-
Background
- Alpha-synuclein is a presynaptic neuronal protein that is thought to be involved in the formation of SNARE complexes. Most significantly, aggregated alpha-synuclein is one of the major components found in the Lewy bodies that occur in Parkinson's disease (PD) and other neurodegenerative disorders (Okochi et al., 2000). Mutation of the alpha-synuclein gene is associated with familial forms of PD (Newmann et al., 2002). Recent evidence suggests that phosphorylation of alpha-synuclein at ser129 plays a role in the formation of inclusions in PD (Smith et al., 2005, Masliah et al., 2005).Synonyms: NACP, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, PARK1
-
Gene ID
- 29219
-
NCBI Accession
- NP_062042
-
UniProt
- P37377
-
Pathways
- Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Platelet-derived growth Factor Receptor Signaling, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Target
-